
Stars and their eyes… Ashton Kutcher
US actor and venture capitalist Ashton Kutcher has revealed he suffered from a rare autoimmune disease, vasculitis, impacting his vision, hearing and mobility.

US actor and venture capitalist Ashton Kutcher has revealed he suffered from a rare autoimmune disease, vasculitis, impacting his vision, hearing and mobility.

The UK's Association of Optometrists (AOP) has launched a national campaign following a Freedom of Information request revealing at least 200 patients have lost their sight due to NHS backlogs since

The International Opticians’ Association (IOA) has opened entries for the Silmo IOA International Optician of the Year Award 2023. As well as being a qualified DO in their country of practice, the

Design Eyewear Group’s Nifties and Inface are offering new releases, the former with petite sizing, ranging from 44-50. Nifties’ latest collection features two-tone acetates with a harmonious fusion of materials and colourful transparencies in contemporary, feminine shapes.

Specsavers has welcomed a record number of graduates into the fold in 2023, with 168 newly qualified optometrists joining the business across Australia and New Zealand.

Marrying style and innovation, Blackfin’s new sun collection expands the brand’s technical DNA and trademark design. Featuring contrasting matte colours and polished details, this three-piece titanium collection is elegant with decisively modern aesthetics. Copeland, featured here, is available in t

Monoqool’s 3D-printed eyewear collections continue to offer choice in contemporary, everyday eyewear, produced in Denmark from polyamide combined with lightweight surgical stainless steel.

After facing backlash from around 3,000 members of the UK’s Association of Optometrists (AOP), the General Optical Council (GOC) has scrapped its proposal to permit dispensing opticians (DOs) to carry

Researchers in Japan have begun what they said is the first study of the effects of multifocal contact lenses (CLs) and low-dose atropine on axial length in young myopes. Led by Dr Takahiro Hiraoka,

Be My Eyes, a company dedicated to improving accessibility for people who are blind or have low vision, is beta testing its new Virtual Volunteer tool, soon to be integrated into the Be My Eyes

West Australian researchers have developed a breakthrough method to measure the brain fluid pressure in humans, which may reduce vision damage experienced by astronauts on long-haul space flights. A

California-based Skye Bioscience completed dosing its third cohort of eight healthy participants in its phase 1 clinical trial of SBI-100, a synthetic cannabinoid derivative designed to treat glaucoma